Pacira Pharmaceuticals Stock Price History
| PCRX Stock | USD 26.25 0.15 0.57% |
Below is the normalized historical share price chart for Pacira Pharmaceuticals extending back to February 03, 2011. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pacira Pharmaceuticals stands at 26.25, as last reported on the 19th of April, with the highest price reaching 26.34 and the lowest price hitting 25.91 during the day.
If you're considering investing in Pacira Stock, it is important to understand the factors that can impact its price. Pacira Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.15, which implies the firm had a -0.15% return per unit of risk over the last 3 months. Pacira Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pacira Pharmaceuticals' Risk Adjusted Performance of (0.08), variance of 4.17, and Coefficient Of Variation of (673.44) to confirm the risk estimate we provide.
At this time, Pacira Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 1.7 B in 2024, whereas Common Stock Total Equity is likely to drop slightly above 32.8 K in 2024. . At this time, Pacira Pharmaceuticals' Price Earnings Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to rise to 11.74 in 2024, whereas Price To Sales Ratio is likely to drop 2.19 in 2024. Pacira Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of February 2011 | 200 Day MA 31.682 | 50 Day MA 29.0484 | Beta 0.753 |
Pacira |
Sharpe Ratio = -0.1535
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PCRX |
Estimated Market Risk
| 2.06 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.32 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pacira Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pacira Pharmaceuticals by adding Pacira Pharmaceuticals to a well-diversified portfolio.
Price Book 1.4349 | Enterprise Value Ebitda 10.0657 | Price Sales 1.8484 | Shares Float 46 M | Wall Street Target Price 46.4 |
Pacira Pharmaceuticals Stock Price History Chart
There are several ways to analyze Pacira Stock price data. The simplest method is using a basic Pacira candlestick price chart, which shows Pacira Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 30, 2024 | 33.07 |
| Lowest Price | April 18, 2024 | 26.1 |
Pacira Pharmaceuticals April 19, 2024 Stock Price Synopsis
Various analyses of Pacira Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Pacira Stock. It can be used to describe the percentage change in the price of Pacira Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Pacira Stock.| Pacira Pharmaceuticals Price Daily Balance Of Power | 0.35 | |
| Pacira Pharmaceuticals Price Rate Of Daily Change | 1.01 | |
| Pacira Pharmaceuticals Accumulation Distribution | 7,329 | |
| Pacira Pharmaceuticals Price Action Indicator | 0.20 |
Pacira Pharmaceuticals April 19, 2024 Stock Price Analysis
Pacira Stock Price History Data
The price series of Pacira Pharmaceuticals for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 has a statistical range of 6.97 with a coefficient of variation of 5.48. The price distribution for the period has arithmetic mean of 29.75. The median price for the last 90 days is 29.66.| Open | High | Low | Close | Volume | ||
| 04/19/2024 | 25.98 | 26.34 | 25.91 | 26.25 | 448,972 | |
| 04/18/2024 | 26.79 | 26.84 | 26.08 | 26.10 | 621,147 | |
| 04/17/2024 | 27.02 | 27.14 | 26.36 | 26.77 | 415,509 | |
| 04/16/2024 | 26.43 | 27.63 | 26.29 | 26.87 | 721,374 | |
| 04/15/2024 | 26.89 | 27.04 | 25.76 | 26.53 | 604,436 | |
| 04/12/2024 | 27.29 | 27.29 | 26.61 | 26.83 | 471,623 | |
| 04/11/2024 | 28.09 | 28.09 | 27.22 | 27.36 | 323,567 | |
| 04/10/2024 | 27.89 | 28.38 | 27.52 | 27.83 | 444,858 | |
| 04/09/2024 | 28.60 | 28.84 | 27.98 | 28.52 | 363,924 | |
| 04/08/2024 | 28.10 | 28.73 | 28.10 | 28.48 | 326,414 | |
| 04/05/2024 | 28.37 | 28.45 | 27.94 | 28.16 | 415,395 | |
| 04/04/2024 | 29.05 | 29.47 | 28.18 | 28.40 | 403,192 | |
| 04/03/2024 | 28.33 | 29.12 | 28.26 | 29.01 | 307,484 | |
| 04/02/2024 | 28.80 | 29.17 | 28.31 | 28.51 | 477,032 | |
| 04/01/2024 | 29.44 | 29.44 | 28.43 | 29.15 | 335,223 | |
| 03/28/2024 | 29.15 | 29.58 | 28.86 | 29.22 | 569,631 | |
| 03/27/2024 | 28.73 | 29.30 | 28.36 | 29.04 | 556,686 | |
| 03/26/2024 | 29.48 | 29.48 | 28.25 | 28.51 | 531,750 | |
| 03/25/2024 | 28.87 | 29.40 | 28.60 | 29.23 | 383,010 | |
| 03/22/2024 | 29.37 | 29.45 | 28.44 | 28.67 | 360,010 | |
| 03/21/2024 | 30.16 | 30.39 | 29.22 | 29.29 | 535,719 | |
| 03/20/2024 | 29.40 | 30.16 | 29.08 | 30.02 | 276,565 | |
| 03/19/2024 | 29.23 | 29.72 | 28.87 | 29.47 | 287,321 | |
| 03/18/2024 | 29.42 | 29.62 | 28.70 | 29.29 | 328,012 | |
| 03/15/2024 | 29.02 | 29.68 | 28.82 | 29.41 | 1,256,448 | |
| 03/14/2024 | 30.27 | 30.27 | 29.11 | 29.26 | 445,730 | |
| 03/13/2024 | 30.57 | 30.95 | 29.89 | 30.29 | 369,964 | |
| 03/12/2024 | 31.11 | 31.46 | 30.51 | 30.56 | 260,206 | |
| 03/11/2024 | 30.98 | 31.45 | 30.83 | 31.02 | 444,129 | |
| 03/08/2024 | 30.66 | 31.43 | 30.34 | 31.41 | 527,869 | |
| 03/07/2024 | 30.40 | 31.47 | 30.25 | 30.64 | 626,723 | |
| 03/06/2024 | 29.50 | 30.11 | 28.96 | 30.11 | 569,362 | |
| 03/05/2024 | 29.14 | 29.45 | 28.62 | 29.44 | 452,644 | |
| 03/04/2024 | 28.40 | 29.50 | 27.89 | 29.20 | 711,607 | |
| 03/01/2024 | 29.69 | 30.01 | 28.68 | 28.86 | 662,201 | |
| 02/29/2024 | 29.45 | 30.52 | 28.61 | 29.72 | 768,357 | |
| 02/28/2024 | 29.57 | 30.26 | 29.30 | 29.91 | 540,662 | |
| 02/27/2024 | 30.16 | 30.20 | 29.67 | 29.85 | 497,586 | |
| 02/26/2024 | 29.97 | 30.32 | 29.56 | 29.74 | 351,727 | |
| 02/23/2024 | 30.00 | 30.34 | 29.46 | 30.04 | 348,524 | |
| 02/22/2024 | 29.75 | 29.98 | 29.35 | 29.97 | 358,324 | |
| 02/21/2024 | 29.82 | 29.96 | 29.52 | 29.70 | 299,859 | |
| 02/20/2024 | 28.86 | 29.88 | 28.86 | 29.86 | 401,452 | |
| 02/16/2024 | 29.64 | 29.81 | 29.08 | 29.08 | 350,012 | |
| 02/15/2024 | 29.45 | 29.93 | 29.37 | 29.66 | 286,786 | |
| 02/14/2024 | 29.59 | 29.65 | 29.00 | 29.23 | 286,688 | |
| 02/13/2024 | 29.16 | 29.91 | 28.94 | 29.21 | 360,715 | |
| 02/12/2024 | 28.92 | 30.04 | 28.92 | 30.02 | 644,682 | |
| 02/09/2024 | 27.75 | 28.97 | 27.65 | 28.78 | 604,034 | |
| 02/08/2024 | 28.55 | 28.87 | 27.37 | 27.70 | 1,319,215 | |
| 02/07/2024 | 30.14 | 30.15 | 28.45 | 28.49 | 1,045,043 | |
| 02/06/2024 | 31.12 | 31.17 | 30.55 | 30.78 | 501,176 | |
| 02/05/2024 | 30.08 | 31.48 | 29.98 | 31.14 | 633,569 | |
| 02/02/2024 | 31.08 | 31.15 | 30.14 | 30.34 | 1,217,529 | |
| 02/01/2024 | 32.65 | 32.65 | 31.70 | 31.78 | 549,997 | |
| 01/31/2024 | 33.06 | 34.01 | 32.49 | 32.59 | 584,774 | |
| 01/30/2024 | 33.64 | 33.64 | 32.35 | 33.07 | 554,307 | |
| 01/29/2024 | 32.02 | 32.82 | 31.50 | 32.47 | 375,718 | |
| 01/26/2024 | 32.67 | 32.77 | 32.03 | 32.05 | 267,408 | |
| 01/25/2024 | 32.63 | 32.78 | 31.96 | 32.39 | 249,614 | |
| 01/24/2024 | 32.78 | 32.95 | 31.63 | 32.18 | 287,853 |
About Pacira Pharmaceuticals Stock history
Pacira Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pacira is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pacira Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pacira Pharmaceuticals stock prices may prove useful in developing a viable investing in Pacira Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 52 M | 35.9 M | |
| Net Income Applicable To Common Shares | 18.3 M | 19.2 M |
Pacira Pharmaceuticals Quarterly Net Working Capital |
|
Pacira Pharmaceuticals Stock Technical Analysis
Pacira Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Pacira Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pacira Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Pacira Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pacira to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | (0.36) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacira Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pacira Stock please use our How to Invest in Pacira Pharmaceuticals guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Pacira Stock analysis
When running Pacira Pharmaceuticals' price analysis, check to measure Pacira Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira Pharmaceuticals is operating at the current time. Most of Pacira Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pacira Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pacira Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Pacira Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacira Pharmaceuticals. If investors know Pacira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacira Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.291 | Earnings Share 0.89 | Revenue Per Share 14.603 | Quarterly Revenue Growth 0.054 | Return On Assets 0.0335 |
The market value of Pacira Pharmaceuticals is measured differently than its book value, which is the value of Pacira that is recorded on the company's balance sheet. Investors also form their own opinion of Pacira Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pacira Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacira Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pacira Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacira Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacira Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacira Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.